Intavis Peptide Services

Intavis Peptide Services a peptide focused CDMO Founded in the late 1990s Intavis Peptide Services (IPS) has around 30 years of experience in peptide synthesis. As a part of the Intavis Instruments corporation IPS initially synthesized peptides to validate analytical instruments. However, when the scientific and medical community realized the great potential of peptide drugs, such as Insulin and many more peptide-based blockbusters, Invtavis expanded its custom peptide synthesis division. Until today, IPS has contributed to many research projects and partnered with global companies. IPS provides comprehensive service around customized peptide synthesis from project inception to final peptide-based medicinal product....

Custom peptides,peptide libraries,spot peptides,peptide arrays,celluspots,synthetic resins,gmp,fill & finish,neoantigens,vaccine,peptide nucleic acids (pna),peptide assays,neoantigen peptide vaccine,and radioligand therapy

Intavis peptide services operates in the Biotechnology research industry.

Intavis peptide services's revenue is 11m - 100m

Intavis peptide services has 11 - 50 employees.